The Pharma Legal Handbook: Serbia

Serbia is covered comprehensively in The Pharma Legal Handbook: Serbia, developed with leading local law firm. The handbook addresses the full pharmaceutical regulatory lifecycle in Serbia, providing authoritative guidance on the questions that regulatory affairs, market access and legal professionals encounter in practice.

It covers product registration and authorisation with ALIMS (Medicines and Medical Devices Agency of Serbia), pricing and reimbursement frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing and promotional rules, and intellectual property protection. Each chapter is written by practising lawyers with direct experience of pharmaceutical regulation in Serbia.

Whether you are preparing a Serbia market entry strategy, managing an existing product portfolio, or advising clients on local pharmaceutical law, this handbook gives you the regulatory knowledge you need in a single structured reference. Updated to reflect current requirements.